FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921188603> ?p ?o ?g. }

• W2921188603 endingPage "e190429" @default.
• W2921188603 startingPage "e190429" @default.
• W2921188603 abstract "Deaths from cancer are attributed more to secondary than primary tumors, but the pathogenesis of organ-specific cancer metastasis has not been determined.To investigate whether precancer osteoporosis and osteoporosis therapy are associated with alteration of bone metastasis patterns.This nationwide retrospective cohort study was performed from January 1, 2002, to December 31, 2013, using 2 cohorts from the Taiwan National Health Insurance Research Database: a random sample of 1 million beneficiaries from the Longitudinal Health Insurance Database who were enrolled in 2005 (LHID2005) and a specific data set of all the patients with osteoporosis. Patients diagnosed with breast cancer and precancer osteoporosis from January 1, 2002, to December 31, 2011, were included in the study, and their records were examined through December 31, 2013. From LHID2005, we selected 9104 women with early-stage breast cancer, of whom 705 had precancer osteoporosis. We identified 29 183 patients from the cohort of patients with breast cancer and osteoporosis, 14 020 of whom had precancer osteoporosis. Data analysis was performed from December 31, 2016, to August 31, 2018.Precancer osteoporosis and osteoporosis therapy.The risk of bone metastasis in patients with and without precancer osteoporosis and patients receiving and not receiving osteoporosis therapy as well as time to bone metastasis development.Among 9104 patients with breast cancer from the Longitudinal Health Insurance Database (mean [SD] age, 46.7 [14.0] years), precancer osteoporosis was not associated with a difference in risk of bone metastasis (adjusted hazard ratio [aHR], 0.87; 95% CI, 0.58-1.30; P = .49). Among 14 020 patients with precancer osteoporosis from the other cohort (mean [SD] age, 58.9 [11.6] years), osteoporosis therapy had no association with the risk of bone metastasis (bisphosphonates: aHR, 1.47; 95% CI, 1.00-2.17; P = .05; nonbisphosphonate drugs: aHR, 1.00; 95% CI, 0.72-1.39; P > .99). Compared with those without precancer osteoporosis (median time to bone metastasis development, 2.87 years; interquartile range [IQR], 1.34-4.86 years), among those with precancer osteoporosis, the median time to develop bone metastasis was shorter in those who did not receive treatment (1.74 years; IQR, 0.58-3.60 years; P < .001), whereas this time was the same for those who received treatment (bisphosphonates: 2.34 years; IQR, 1.23-3.13 years; nonbisphosphonate drugs: 2.08 years; IQR, 0.92-4.95 years).Precancer osteoporosis was not associated with risk of bone metastasis, but untreated osteoporosis was associated with accelerated progression of bone metastasis when it occurred. Organ microenvironments interact with disseminated cancer mostly after the specific organ has been predetermined to be the designated location. Because recurrences and metastases are major obstacles to cancer treatments, determining which organs may be at risk for metastases may be crucial to treating the disease." @default.
• W2921188603 created "2019-03-22" @default.
• W2921188603 creator A5034769871 @default.
• W2921188603 creator A5043697093 @default.
• W2921188603 creator A5055306575 @default.
• W2921188603 creator A5068781918 @default.
• W2921188603 date "2019-03-08" @default.
• W2921188603 modified "2023-10-16" @default.
• W2921188603 title "Association of Bone Metastasis With Early-Stage Breast Cancer in Women With and Without Precancer Osteoporosis According to Osteoporosis Therapy Status" @default.
• W2921188603 cites W1520425169 @default.
• W2921188603 cites W175076184 @default.
• W2921188603 cites W1959544975 @default.
• W2921188603 cites W1964736329 @default.
• W2921188603 cites W1967451684 @default.
• W2921188603 cites W1967894062 @default.
• W2921188603 cites W1985727076 @default.
• W2921188603 cites W1991717909 @default.
• W2921188603 cites W2003213153 @default.
• W2921188603 cites W2025668946 @default.
• W2921188603 cites W2042633087 @default.
• W2921188603 cites W2070086300 @default.
• W2921188603 cites W2081197989 @default.
• W2921188603 cites W2087324367 @default.
• W2921188603 cites W2089370460 @default.
• W2921188603 cites W2100376124 @default.
• W2921188603 cites W2102969047 @default.
• W2921188603 cites W2104872826 @default.
• W2921188603 cites W2111807012 @default.
• W2921188603 cites W2116836111 @default.
• W2921188603 cites W2117668915 @default.
• W2921188603 cites W2131849450 @default.
• W2921188603 cites W2138691465 @default.
• W2921188603 cites W2144744111 @default.
• W2921188603 cites W2165011173 @default.
• W2921188603 cites W2166538093 @default.
• W2921188603 cites W2189916683 @default.
• W2921188603 cites W2396599501 @default.
• W2921188603 cites W2492441292 @default.
• W2921188603 cites W2610710927 @default.
• W2921188603 cites W4234533865 @default.
• W2921188603 doi "https://doi.org/10.1001/jamanetworkopen.2019.0429" @default.
• W2921188603 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6484629" @default.
• W2921188603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30848812" @default.
• W2921188603 hasPublicationYear "2019" @default.
• W2921188603 type Work @default.
• W2921188603 sameAs 2921188603 @default.
• W2921188603 citedByCount "19" @default.
• W2921188603 countsByYear W29211886032019 @default.
• W2921188603 countsByYear W29211886032020 @default.
• W2921188603 countsByYear W29211886032021 @default.
• W2921188603 countsByYear W29211886032022 @default.
• W2921188603 countsByYear W29211886032023 @default.
• W2921188603 crossrefType "journal-article" @default.
• W2921188603 hasAuthorship W2921188603A5034769871 @default.
• W2921188603 hasAuthorship W2921188603A5043697093 @default.
• W2921188603 hasAuthorship W2921188603A5055306575 @default.
• W2921188603 hasAuthorship W2921188603A5068781918 @default.
• W2921188603 hasBestOaLocation W29211886031 @default.
• W2921188603 hasConcept C121608353 @default.
• W2921188603 hasConcept C126322002 @default.
• W2921188603 hasConcept C143998085 @default.
• W2921188603 hasConcept C167135981 @default.
• W2921188603 hasConcept C207103383 @default.
• W2921188603 hasConcept C2776541429 @default.
• W2921188603 hasConcept C2777783956 @default.
• W2921188603 hasConcept C2779013556 @default.
• W2921188603 hasConcept C44249647 @default.
• W2921188603 hasConcept C530470458 @default.
• W2921188603 hasConcept C71924100 @default.
• W2921188603 hasConcept C72563966 @default.
• W2921188603 hasConceptScore W2921188603C121608353 @default.
• W2921188603 hasConceptScore W2921188603C126322002 @default.
• W2921188603 hasConceptScore W2921188603C143998085 @default.
• W2921188603 hasConceptScore W2921188603C167135981 @default.
• W2921188603 hasConceptScore W2921188603C207103383 @default.
• W2921188603 hasConceptScore W2921188603C2776541429 @default.
• W2921188603 hasConceptScore W2921188603C2777783956 @default.
• W2921188603 hasConceptScore W2921188603C2779013556 @default.
• W2921188603 hasConceptScore W2921188603C44249647 @default.
• W2921188603 hasConceptScore W2921188603C530470458 @default.
• W2921188603 hasConceptScore W2921188603C71924100 @default.
• W2921188603 hasConceptScore W2921188603C72563966 @default.
• W2921188603 hasIssue "3" @default.
• W2921188603 hasLocation W29211886031 @default.
• W2921188603 hasLocation W29211886032 @default.
• W2921188603 hasLocation W29211886033 @default.
• W2921188603 hasLocation W29211886034 @default.
• W2921188603 hasOpenAccess W2921188603 @default.
• W2921188603 hasPrimaryLocation W29211886031 @default.
• W2921188603 hasRelatedWork W1968362482 @default.
• W2921188603 hasRelatedWork W2055804777 @default.
• W2921188603 hasRelatedWork W2057553101 @default.
• W2921188603 hasRelatedWork W2358452104 @default.
• W2921188603 hasRelatedWork W2365008957 @default.
• W2921188603 hasRelatedWork W3004855635 @default.
• W2921188603 hasRelatedWork W3033874287 @default.
• W2921188603 hasRelatedWork W3088410393 @default.
• W2921188603 hasRelatedWork W3112166790 @default.

• next